![Mark McDonnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark McDonnell
Keine laufenden Positionen mehr
Health Technology
Profil
Mark McDonnell worked as Chief Chemist at Neuropathix, Inc. Former job includes Chief Chemist at Neuropathix, Inc.
Ehemalige bekannte Positionen von Mark McDonnell
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | 01.09.2024 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapeutics for inflammatory & neuropathic pain related diseases | Health Technology |
